Evidence map›Paper›PMID 36144306›Full record

ReviewMicroorganisms2022

Use of Probiotic Bacteria and Bacteriocins as an Alternative to Antibiotics in Aquaculture.

Wellison Amorim Pereira, Carlos Miguel N Mendonça, Alejandro Villasante Urquiza, Viggó Þór Marteinsson, Jean Guy LeBlanc, Paul D Cotter, Elías Figueroa Villalobos, Jaime Romero, Ricardo P S Oliveira

Open access · goldAbstract readReview
In one paragraph

Review in Microorganisms, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 79 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. In vitro characterization of probiotic properties of isolated and grown co-cultures on halophyte-based substrate.International microbiology : the official journal of the Spanish Society for Microbiology · 2026
    Article
  8. Review
  9. Dietary Encapsulation of a NovelAntioxidants (Basel, Switzerland) · 2026
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Microorganisms · 2025
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 4 countries.

Wellison Amorim PereiraMicrobial Biomolecules Laboratory, Faculty of Pharmaceutical Sciences, São Paulo University, Rua do Lago 250, Cidade Universitária, São Paulo 05508-000, SP, Brazil.
Carlos Miguel N MendonçaMicrobial Biomolecules Laboratory, Faculty of Pharmaceutical Sciences, São Paulo University, Rua do Lago 250, Cidade Universitária, São Paulo 05508-000, SP, Brazil.
Alejandro Villasante UrquizaFacultad de Medicina Veterinaria y Agronomía, Universidad de Las Américas, Santiago 7500000, Chile.ORCID 0000-0002-7568-8204
Viggó Þór MarteinssonMatís OHF, Microbiology Research Group, Vínlandsleið 12, 113 Reykjavík, Iceland.ORCID 0000-0001-8340-821X
Jean Guy LeBlancCentro de Referencia para Lactobacilos (CERELA-CONICET), San Miguel de Tucuman T4000, Argentina.ORCID 0000-0002-4634-8630
Paul D CotterTeagasc Food Research Centre, Moorepark, APC Microbiome Ireland, T12 K8AF Cork, Ireland.ORCID 0000-0002-5465-9068
Elías Figueroa VillalobosNucleus of Research in Food Production, Faculty of Natural Resources, Catholic University of Temuco, Temuco 4780000, Chile.
Jaime RomeroLaboratorio de Biotecnología de Alimentos, Instituto de Nutricion y Tecnologia de los Alimentos (INTA), Universidad de Chile, El Libano 5524, Santiago 783090, Chile.ORCID 0000-0001-9614-2393
Ricardo P S OliveiraMicrobial Biomolecules Laboratory, Faculty of Pharmaceutical Sciences, São Paulo University, Rua do Lago 250, Cidade Universitária, São Paulo 05508-000, SP, Brazil.ORCID 0000-0001-8590-804X
Consejo Nacional de Investigaciones Científicas y Técnicas · ARMatís (Iceland) · ISTeagasc - The Irish Agriculture and Food Development Authority · IEUniversidad Católica de Temuco · CLUniversity of Chile · CLUniversity of the Americas · CL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In addition to their use in human medicine, antimicrobials are also used in food animals and aquaculture, and their use can be categorized as therapeutic against bacterial infections. The use of antimicrobials in aquaculture may involve a broad environmental application that affects a wide variety of bacteria, promoting the spread of bacterial resistance genes. Probiotics and bacteriocins, antimicrobial peptides produced by some types of lactic acid bacteria (LAB), have been successfully tested in aquatic animals as alternatives to control bacterial infections. Supplementation might have beneficial impacts on the intestinal microbiota, immune response, development, and/or weight gain, without the issues associated with antibiotic use. Thus, probiotics and bacteriocins represent feasible alternatives to antibiotics. Here, we provide an update with respect to the relevance of aquaculture in the animal protein production sector, as well as the present and future challenges generated by outbreaks and antimicrobial resistance, while highlighting the potential role of probiotics and bacteriocins to address these challenges. In addition, we conducted data analysis using a simple linear regression model to determine whether a linear relationship exists between probiotic dose added to feed and three variables of interest selected, including specific growth rate, feed conversion ratio, and lysozyme activity.

Indexed as

antibioticaquaculturebacteriocinbiotechnologyprobiotic

Identifiers

PMID36144306
PMCPMC9503917
OpenAlexW4293220698

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.